BDBM50000867 7-(4-Hydroxy-pentyloxy)-1,3-dihydro-imidazo[4,5-b]quinolin-2-one::CHEMBL91359

SMILES CC(O)CCCOc1ccc2nc3[nH]c(=O)[nH]c3cc2c1

InChI Key InChIKey=AOAQFGRPXBJZPI-UHFFFAOYSA-N

Data  1 IC50  2 EC50

Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50000867   

TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50000867(7-(4-Hydroxy-pentyloxy)-1,3-dihydro-imidazo[4,5-b]...)
Show SMILES CC(O)CCCOc1ccc2nc3[nH]c(=O)[nH]c3cc2c1
Show InChI InChI=1S/C15H17N3O3/c1-9(19)3-2-6-21-11-4-5-12-10(7-11)8-13-14(16-12)18-15(20)17-13/h4-5,7-9,19H,2-3,6H2,1H3,(H2,16,17,18,20)
Affinity DataIC50: 100nMAssay Description:Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
Target3',5'-cyclic-AMP phosphodiesterase(Sus scrofa)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50000867(7-(4-Hydroxy-pentyloxy)-1,3-dihydro-imidazo[4,5-b]...)
Show SMILES CC(O)CCCOc1ccc2nc3[nH]c(=O)[nH]c3cc2c1
Show InChI InChI=1S/C15H17N3O3/c1-9(19)3-2-6-21-11-4-5-12-10(7-11)8-13-14(16-12)18-15(20)17-13/h4-5,7-9,19H,2-3,6H2,1H3,(H2,16,17,18,20)
Affinity DataEC50:  520nMAssay Description:Inhibition of ADP-induced platelet aggregation in rabbit platelet rich plasma (PRP)More data for this Ligand-Target Pair
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50000867(7-(4-Hydroxy-pentyloxy)-1,3-dihydro-imidazo[4,5-b]...)
Show SMILES CC(O)CCCOc1ccc2nc3[nH]c(=O)[nH]c3cc2c1
Show InChI InChI=1S/C15H17N3O3/c1-9(19)3-2-6-21-11-4-5-12-10(7-11)8-13-14(16-12)18-15(20)17-13/h4-5,7-9,19H,2-3,6H2,1H3,(H2,16,17,18,20)
Affinity DataEC50:  100nMAssay Description:Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)More data for this Ligand-Target Pair